Drug Index

Anakinra


Indication :

  • Chronic Infantile Neurologic Cutaneous Articular Syndrome (CINCA).
  • Safety not established for use in JIA in children.

Dosing :

1-2 mg/kg SC every day. Can increase upto 8 g/kg.

Adverse Effect :

Injection site reaction, headache, vomiting, arthralgia, fever, URI, nausea, diarrhea, neutropenia, hepatitis, hypercholesterolemia, thrombocytopenia.


Hepatic Dose :

No dosage adjustments are recommended.
01/28/2024 15:31:00 Anakinra
Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0